AHWP 'Striking Out' With Combination Products Guidance
This article was originally published in SRA
The Asian Harmonization Working Party has published several guidance documents that were finalized at its annual meeting in Bangkok last November, including a white paper reviewing current international practice on the regulation of combination products and associated challenges and risks1,2.
You may also be interested in...
A draft guideline issued by the Asian Harmonization Working Party focuses on how regulators can minimize duplication when they evaluate combination products, and ensure the “rigor and quality” of reviews.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.